INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2020

Ginseng supplementation was associated with reduced incidence and duration of seasonal acute upper respiratory infections, though risk of bias was high-to-unclear.

A systematic review and meta-analysis evaluated nine articles covering ten clinical trials investigating Panax ginseng or Panax quinquefolius for the prevention or treatment of seasonal acute upper respiratory infections (SAURIs). Quantitative synthesis showed a significant reduction in SAURI incidence (RR = 0.69 [95% CI 0.52 to 0.90], p < 0.05) and a significant reduction in duration among healthy individuals (MD = -3.11 [95% CI -5.81 to -0.40], p < 0.05), particularly as an adjunct to influenza vaccination. However, the risk of bias was high-to-unclear for most trials and publication bias could not be excluded, preventing definitive conclusions.

Study type
Systematic review and meta-analysis of clinical trials
Who was studied
Individuals across 10 trials described in 9 articles
What was measured
Seasonal acute upper respiratory infections (SAURIs) incidence and duration

THE PAPER

Ginseng integrative supplementation for seasonal acute upper respiratory infections: A systematic review and meta-analysis.

Antonelli M, Donelli D, Firenzuoli F. Complement Ther Med, 2020.

PubMed 32951718 ↗DOI 10.1089/cap.2014.0013 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.